Wegovy and Mounjaro: who will actually get reimbursed in France
The two obesity medications Wegovy and Mounjaro could benefit from reimbursement, but access criteria remain highly restrictive.
Published 17sem·4 sources✓ ConfirmedNotable·updated 6sem
The fact
Social Security is considering limited reimbursement for patients with serious metabolic complications associated with overweight.
These decisions will depend on ongoing negotiations with pharmaceutical manufacturers and recommendations from the French Health Authority.
🔗4 sources — click a link to read an article on the topic:
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.→France · © OpenStreetMap, OpenMapTiles, OpenFreeMapWorld map →Auto-synthesis from 4 media sources · identified on May 28, 2026